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Volume 58, Number 2 Kresowik 419degree, symptom status. The new iteration of NSQIP, as
it captures procedure-speciﬁc comorbid conditions and
complications, will make this an even more robust database
in the future.
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This report by Bensley et al emphasizes the important concept
that databases are not all “created equal,” and thus, it is essential
that the limitations of any database be recognized when drawing
conclusions from analyses. Some of the differences identiﬁed in
their report are a result of differences in deﬁnition between data-
bases rather than “accuracy” per se. This has long been a problem
for carotid procedures.
By far, the most important patient-related determinant of risk
for a carotid intervention is symptom status. Problems arise from
the historic division of symptom status into only two stratad
symptomatic and asymptomaticdand that clinical reports and even
randomized trials have used different deﬁnitions of symptomatic.
I submit that at least three levels of cerebrovascular symptom
status and standardized deﬁnitions are necessary: asymptomatic(never symptomatic in any distribution), symptomatic (recent,
ipsilateral hemispheric or ocular symptoms), and other symptom-
atic (remote ipsilateral or any contralateral or global/vertebrobasi-
lar symptoms). The use of these three strata and deﬁnitions reliably
predict the risk of carotid endarterectomy.1
The current report clearly identiﬁes some of the limitations of
current administrative databases vis-à-vis clinical registries. I do not
think, however, that one can assume that clinical registries, such as
the National Surgical Quality Improvement Program or the
Society for Vascular Surgery Vascular Quality Initiative, are feasible
or even necessarily superior to administrative databases for all the
potential uses of procedural outcome data. There is tremendous
current pressure to have outcome performance measures available
for accountability, such as public reporting or pay-for-performance
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100% of the procedures and providers doing those procedures.
Clinical registries depend on voluntary participation and will never
have this attribute, even if deﬁnitions could be harmonized among
different registries, which is challenging in itself.
In addition, it cannot be assumed that the validity of registry
data will be the same if the results are to be used for accountability
rather than conﬁdential quality improvement. The Society for
Vascular Surgery Quality and Performance Measure Committee
has been developing enhancements to procedural claims reporting
that should allow valid procedural outcome comparisons between
providers in the areas of carotid intervention and aortic aneurysm
repair with minimal burden on providers.2
Having valid accountability measures based on enhanced
administrative data sets is complementary to rather than competi-tive with clinical registries. Clinical registries or medical record
review, or both, will always be necessary for quality improvement
initiatives as well as clinical research. In my opinion, they will
never be sufﬁcient or suitable for accountability performance
measurement.REFERENCES
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